Biotechnology Assets

Contact

Logo Biotechnology Assets

Contact information

Biotechnology Assets

Victor Infante, Vicepresidente Ejecutivo

corporatecommunications@biatgroup.com

Av. Desarrollo Tecnológico 11.

Jerez de la Frontera

Cádiz

856818424

https://biatgroup.com/

Areas of activities

A. Health Biotechnology
- Areas of activity
  - Biodrugs
  - In vitro diagnostics
  - Vaccines
- Therapeutic areas
  - Genetic and rare diseases
  - Infectious diseases
  - Immunology
B. Agrifood Biotechnology
- Agriculture / veterinary / environmental
  - Animal health / Veterinary
D. Services
- Professional services
CRO / CMO / SMO

Commissions

Healthcare Committee

Boost the Ecosystem Committee

Description

Biat Group is a biotechnology corporate group formed by various subsidiaries and a global commercial structure.

Under the corporate umbrella of the group holding (Bionatur) a global business and commercial network to promote Biobide, ZIP Solutions, and Bionatur assets.

Products and services

1) Biobide (Donosti and Boston) is a worldwide leader in the zebrafish (ZF) animal model offering tailor-made toxicity and efficacy testing. ZF gathers together all in one the best features of in-vitro and in-vivo testing.

2) ZIP Solutions (Barcelona) promotes its unique proprietary set of inteins in many high value industrial applications: Click-gene for gene therapy; Click-bio for immunotherapy; Click-Dx for IVD; Click-VLP for smart vaccines; Vacc-Zera for RNA & DNA vaccines; and Click-DSP for affinity-based protein purification.

3) Bionatur (Jerez de la Frontera). Biotech unique assets for human and animal health.

Areas of interest for future collaborations

Licensing of biotech platforms and products; Toxicity and efficacy preclinical research; Improvement of recombinant and DNA vaccines

Pipeline

Biotech Sanitaria

Research Platforms
Product / Service	Type	Development phase
CLICK´N CUT	Other	Preclinical
CLICK-VLP	Drug Delivery, Enabling Technologies	Clinical Validation
CLICK-CAR	Drug Delivery, Enabling Technologies	Preclinical
VACC-ZERA paltform	Drug Delivery, Enabling Technologies	Clinical Validation
BBD-ZFM	CMO, CRO	Registration
CLICK-BIO	CMO, CRO, Screening/Drug Discovery	Registration
CLICK-GENE	CRO, CMO, Enabling Technologies	Preclinical
CLICK-TARGET	CRO, CMO, Drug Delivery, Enabling Technologies	Preclinical

Diagnostics and Personalised Medicine
Product / Service	Type	Development phase
CLICK-DIAGNOSTIC	Diagnostic	R&D

Other Technologies
Product / Service	Development phase
CLICK-DSP	R&D

Biotech Agroalimentaria

Veterinary Drugs
Product / Service	Therapeutic area	Development phase
BNT025 (MUPIPET)	Enfermedades infecciosas	P II